1. Home
  2. LUNR vs NUVB Comparison

LUNR vs NUVB Comparison

Compare LUNR & NUVB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LUNR
  • NUVB
  • Stock Information
  • Founded
  • LUNR 2013
  • NUVB 2018
  • Country
  • LUNR United States
  • NUVB United States
  • Employees
  • LUNR N/A
  • NUVB N/A
  • Industry
  • LUNR Industrial Machinery/Components
  • NUVB Biotechnology: Pharmaceutical Preparations
  • Sector
  • LUNR Industrials
  • NUVB Health Care
  • Exchange
  • LUNR Nasdaq
  • NUVB Nasdaq
  • Market Cap
  • LUNR 1.3B
  • NUVB 1.1B
  • IPO Year
  • LUNR N/A
  • NUVB N/A
  • Fundamental
  • Price
  • LUNR $9.15
  • NUVB $3.26
  • Analyst Decision
  • LUNR Buy
  • NUVB Strong Buy
  • Analyst Count
  • LUNR 7
  • NUVB 6
  • Target Price
  • LUNR $13.71
  • NUVB $8.17
  • AVG Volume (30 Days)
  • LUNR 5.2M
  • NUVB 6.7M
  • Earning Date
  • LUNR 11-13-2025
  • NUVB 11-05-2025
  • Dividend Yield
  • LUNR N/A
  • NUVB N/A
  • EPS Growth
  • LUNR N/A
  • NUVB N/A
  • EPS
  • LUNR N/A
  • NUVB N/A
  • Revenue
  • LUNR $225,977,000.00
  • NUVB $14,355,000.00
  • Revenue This Year
  • LUNR $13.03
  • NUVB $332.80
  • Revenue Next Year
  • LUNR $45.16
  • NUVB $360.12
  • P/E Ratio
  • LUNR N/A
  • NUVB N/A
  • Revenue Growth
  • LUNR 42.86
  • NUVB 900.35
  • 52 Week Low
  • LUNR $5.34
  • NUVB $1.54
  • 52 Week High
  • LUNR $24.95
  • NUVB $4.09
  • Technical
  • Relative Strength Index (RSI)
  • LUNR 50.20
  • NUVB 53.12
  • Support Level
  • LUNR $8.19
  • NUVB N/A
  • Resistance Level
  • LUNR $9.42
  • NUVB $3.44
  • Average True Range (ATR)
  • LUNR 0.38
  • NUVB 0.26
  • MACD
  • LUNR 0.14
  • NUVB -0.14
  • Stochastic Oscillator
  • LUNR 78.37
  • NUVB 79.58

About LUNR Intuitive Machines Inc.

Intuitive Machines Inc is a space exploration, infrastructure, and services company. It is a diversified space company focused on space exploration. It supplies space products and services to support sustained robotic and human exploration to the Moon, Mars, and beyond. Its products and services are offered through its four business units: Lunar Access Services, Orbital Services, Lunar Data Services, and Space Products and Infrastructure. The Company operates in one operating segment and one reportable segment underpinned by three core pillars (delivery services, data transmission services, and infrastructure as a service) that have similar capabilities, customers, and economic characteristics. Revenue is from contracts with customers of orbital and lunar access services.

About NUVB Nuvation Bio Inc.

Nuvation Bio Inc is a biopharmaceutical company tackling unmet needs in oncology by developing differentiated and novel therapeutic candidates. Its product candidate, taletrectinib, is an oral, potent, central nervous system-active, selective, next-generation c-ros oncogene 1 (ROS1) inhibitor specifically designed for the treatment of patients with ROS1+ non-small cell lung cancer (NSCLC). In addition, its clinical-stage pipeline includes differentiated, novel oncology product candidates such as Safusidenib, NUV-1511, and NUV-868 in their different stages of development. The company generates revenue through out-licensing collaborative agreements with its customers located in China and Japan.

Share on Social Networks: